Search results
-
Kola Real: La expansión internacional
Ferré, Miguel; Natividad, GabrielCase PAD-DG-C-406EntrepreneurshipDescribe el caso de la internacionalización de una empresa peruana en varios países de la región, partiendo de unos modestos inicios en Ayacucho (1988). Se puede discutir la similitud o diferencias en la forma de nacer según el contexto de cada país.Starting at €8.20
-
Financial Theory Foundations
Schill, Michael J.Technical Note DARDEN-F-1548-EFinanceFinancial theory seeks to explain how buyers and sellers in financial markets price contracts to exchange money across time and across risk profiles. Using rules of agent behavior, theory generates financial models that attempt to predict the fair prices of the securities in financial markets. To make the models simple enough to be used in practice, theorists make simplifying assumptions about the characteristics of markets and market participant...Starting at €8.20
-
Hedged Cost of Funds and Interest Rate Arbitrage
Lipson, Marc L.Technical Note DARDEN-F-1565-EFinanceThis technical note provides an overview of interest rate parity and the hedged cost of international borrowings. The note describes the essential steps to hedge international borrowings with forward contracts and describes in detail the link between forward rates and interest rates and what drives that relationship.Starting at €8.20
-
Nordgold: All-In Sustaining Costs
Lipson, Marc L.Case DARDEN-C-2412-EAccounting and ControlUnderstanding the economics of gold mining had always been a challenge. Gold mines were long-lived assets that required substantial capital investments both to identify and gain access to mineral ore for future processing and to sustain output over the life of a mine. A typical investor might have looked at annual operating margins alone, ignoring these capital outlays, and set unrealistic return expectations. When firms fell short of these expec...Starting at €8.20
-
Crocs, Inc.
Lipson, Marc L.; Gupta, GauravCase DARDEN-F-1589-EFinanceThis case forces students to examine the drivers of value, particularly growth and margins. It is also effective at drawing attention to the relationship between terminal value assumptions and value creation-assumptions that generate a large sensitivity of terminal value to growth rate are assumptions that imply that a great deal of value can still be created from investments after the planning horizon. The narrative features an analyst who is tr...Starting at €8.20
-
Portfolio Selection and the Capital Asset Pricing Model
Lipson, Marc L.Technical Note DARDEN-F-1604-EFinanceIn the context of determining an optimal portfolio to recommend to two hypothetical investors, this structured analysis leads students through a series of steps examining return data for three stocks. The analysis first explores the effects of portfolio formation on returns and volatility. With the addition of a market index and a bond portfolio, students easily recognize how portfolios from these to investment vehicles may be optimal. The analys...Starting at €8.20
-
Rosetta Stone: Pricing the 2009 IPO
Schill, Michael J.; Papireddy, Suprajj; Adams, Tom; Clough, PhilCase DARDEN-F-1613-EFinanceThis case examines the April 2009 decision of Rosetta Stone management to price the initial public offering of Rosetta Stone stock during one of the most difficult periods in capital-raising history. The case outlines Rosetta Stone’s unique language learning strategy and the associated strong financial performance. Students are invited to value the stock and take a position on whether the current $15 to $17 per share filing range is appropriate. ...Starting at €8.20
-
Medfield Pharmaceuticals
Lipson, Marc L.; Mead, Jenny; Harris, Jared D.Case DARDEN-F-1636-EFinanceSusan Johnson, founder and CEO of Medfield Pharmaceuticals, is faced with conflicting recommendations for extending the patent life of the company’s flagship product, Fleximat, scheduled to go off patent in two years. With only three other products in Medfield’s lineup of medications, one of which has only just received U.S. Food and Drug Administration approval, strategic management of the company’s product pipeline is of paramount importance. B...Starting at €8.20
-
Roche Holding AG: Funding the Genentech Acquisition
Schill, Michael J.; Durick, Brett; Chambers, DrewCase DARDEN-F-1645-EFinanceThis case examines the decision by the Swiss pharmaceutical Roche Holding AG (Roche) to offer a record $42 billion bond in February 2009. In light of a pending acquisition of US biotechnology leader Genentech, Roche management planned to sell $32 billion in bonds at various maturities from 1 year to 30 years and in three different currencies (US dollar, euro, and British pound). In a context of substantial uncertainty in both world financial mark...Starting at €8.20
-
Gellibrand Partners
Schill, Michael J.Case DARDEN-F-1648-EFinanceGiven widening bid-ask spread for a target stock, a small Australian portfolio manager considers front-running the market makers by posting its own quotes inside the spread. Organized in a series of rounds, the case asks students to post bid and ask limit orders for shares. Each round allows orders to come in that execute against the limit order book, cash flow and end-of-round inventory to be calculated, and the market to revise the bid and ask ...Starting at €8.20